Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.
Hu HJ, Liang X, Li HL, Wang HY, Gu JF, Sun LY, Xiao J, Hu JQ, Ni AM, Liu XY. Cancer Immunol Immunother. 2021 Dec; 70(12):3541-3555. Epub 2021 Apr 26.